Flibanserin

“SEX IN OUR CITY” SEMINAR TO BE HELD OCT. 20 AT ALVARADO HOSPITAL



 

Event includes Hors d’oeuvres and Discussion on Flibanserin and Other Sexual Health/Relationship Topics for Women

September 7, 2015 (San Diego)-- With FDA approval of the new libido drug for women – flibanserin – women finally have options. This is the first FDA libido drug approved for women, despite the fact that Viagra was approved for men 17 years ago.

San Diego women are invited to attend “Sex in Our City” seminar to learn more about flibanserin (to be marketed as Addyi), as well as what else on the horizon for women in terms of dealing with low sex drives, sexual health in young women and pre- and post-menopause, bedroom secrets to enhance your relationship, hormone treatments and alternatives, and other topics.

LOCAL EXPERT COMMENTS ON FDA APPROVAL OF FIRST DRUG FOR WOMEN WITH LOW LIBIDO

 

Nationally Recognized Sexual Medicine Expert, Dr. Irwin Goldstein of San Diego, Discusses Flibanserin and Lack of Libido Drugs for Women

East County News Service

August 24, 2015 (San Diego) – Although there are 26 drugs approved to treat male sexual dysfunction, there are no drugs specifically approved to increase women’s libido. On August 18,  the FDA approved the first drug, flibanserin—nicknamed “female Viagra.”